Literature DB >> 19542230

Mechanism and regulatory function of CpG signaling via scavenger receptor B1 in primary B cells.

Peimin Zhu1, Xiaohong Liu, Laura S Treml, Michael P Cancro, Bruce D Freedman.   

Abstract

It is well established that CpG promotes pro-inflammatory cytokine and antibody production by B cells via the Toll-like receptor 9 (TLR9)-dependent pathway. However, scavenger receptors (SRs) are also capable of binding such pathogen-derived molecules, yet their contribution to CpG-induced signaling events has not yet been evaluated. Here we identified a novel TLR9-independent mechanism of CpG-induced signaling and immune function that is mediated by the scavenger B1 receptor (SR-B1). Specifically, we show that CpG/SR-B1 triggers calcium entry into primary B lymphocytes via phospholipase C gamma-1-mediated activation of TRPC3 channels and also B cell adhesion to vascular cell adhesion molecule-1. CpG-induced calcium signals and vascular cell adhesion molecule-1 adhesion are TLR9-independent and are mediated exclusively by SR-B1. Although pro-inflammatory cytokine and Ig production induced by CpG require TLR9 expression, we also found that SR-B1 negatively regulates TLR9-dependent production of interleukin-6, interleukin-10, and IgM. Thus, our results provide a novel perspective on the complexity of CpG signaling within B cells by demonstrating that SR-B1 is an alternative pathway for nucleic acid-induced signaling that provides feedback inhibition on specific TLR9-dependent responses of B cells. Consequently, these results have wide implications for understanding the mechanisms regulating immune tolerance to nucleic acids and pathogen-associated molecules.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19542230      PMCID: PMC2755695          DOI: 10.1074/jbc.M109.018580

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  54 in total

Review 1.  New treatments for SLE: cell-depleting and anti-cytokine therapies.

Authors:  Jennifer H Anolik; Martin Aringer
Journal:  Best Pract Res Clin Rheumatol       Date:  2005-10       Impact factor: 4.098

2.  Distinct calcium channels regulate responses of primary B lymphocytes to B cell receptor engagement and mechanical stimuli.

Authors:  Qing-Hua Liu; Xiaohong Liu; Zhiyun Wen; Brian Hondowicz; Leslie King; John Monroe; Bruce D Freedman
Journal:  J Immunol       Date:  2005-01-01       Impact factor: 5.422

3.  Direct activation of human TRPC6 and TRPC3 channels by diacylglycerol.

Authors:  T Hofmann; A G Obukhov; M Schaefer; C Harteneck; T Gudermann; G Schultz
Journal:  Nature       Date:  1999-01-21       Impact factor: 49.962

4.  Mechanisms of hypotonicity-induced calcium signaling and integrin activation by arachidonic acid-derived inflammatory mediators in B cells.

Authors:  Peimin Zhu; Xiaohong Liu; Edward F Labelle; Bruce D Freedman
Journal:  J Immunol       Date:  2005-10-15       Impact factor: 5.422

5.  Encoding of Ca2+ signals by differential expression of IP3 receptor subtypes.

Authors:  T Miyakawa; A Maeda; T Yamazawa; K Hirose; T Kurosaki; M Iino
Journal:  EMBO J       Date:  1999-03-01       Impact factor: 11.598

6.  Phospholipase Cgamma1 controls surface expression of TRPC3 through an intermolecular PH domain.

Authors:  Damian B van Rossum; Randen L Patterson; Sumit Sharma; Roxanne K Barrow; Michael Kornberg; Donald L Gill; Solomon H Snyder
Journal:  Nature       Date:  2005-03-03       Impact factor: 49.962

7.  TLR-9 activation of marginal zone B cells in lupus mice regulates immunity through increased IL-10 production.

Authors:  Petar Lenert; Rachel Brummel; Elizabeth H Field; Robert F Ashman
Journal:  J Clin Immunol       Date:  2005-01       Impact factor: 8.317

8.  Autoreactive B cells discriminate CpG-rich and CpG-poor DNA and this response is modulated by IFN-alpha.

Authors:  Melissa B Uccellini; Liliana Busconi; Nathaniel M Green; Patricia Busto; Sean R Christensen; Mark J Shlomchik; Ann Marshak-Rothstein; Gregory A Viglianti
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

9.  Interleukin 6 dependence of anti-DNA antibody production: evidence for two pathways of autoantibody formation in pristane-induced lupus.

Authors:  H B Richards; M Satoh; M Shaw; C Libert; V Poli; W H Reeves
Journal:  J Exp Med       Date:  1998-09-07       Impact factor: 14.307

10.  Interleukin 6 influences germinal center development and antibody production via a contribution of C3 complement component.

Authors:  M Kopf; S Herren; M V Wiles; M B Pepys; M H Kosco-Vilbois
Journal:  J Exp Med       Date:  1998-11-16       Impact factor: 14.307

View more
  24 in total

1.  Deficiency of scavenger receptor BI leads to impaired lymphocyte homeostasis and autoimmune disorders in mice.

Authors:  Hong Feng; Ling Guo; Dan Wang; Haiqing Gao; Guihua Hou; Zhong Zheng; Junting Ai; Oded Foreman; Alan Daugherty; Xiang-An Li
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11       Impact factor: 8.311

Review 2.  What is the evidence for the role of TRP channels in inflammatory and immune cells?

Authors:  A Parenti; F De Logu; P Geppetti; S Benemei
Journal:  Br J Pharmacol       Date:  2016-02-18       Impact factor: 8.739

Review 3.  Myeloid cells as a target for oligonucleotide therapeutics: turning obstacles into opportunities.

Authors:  Marcin Kortylewski; Dayson Moreira
Journal:  Cancer Immunol Immunother       Date:  2017-02-18       Impact factor: 6.968

4.  Syk is indispensable for CpG-induced activation and differentiation of human B cells.

Authors:  Mariann Kremlitzka; Bernadett Mácsik-Valent; Anna Erdei
Journal:  Cell Mol Life Sci       Date:  2014-12-28       Impact factor: 9.261

5.  Benzo-fused lactams from a diversity-oriented synthesis (DOS) library as inhibitors of scavenger receptor BI (SR-BI)-mediated lipid uptake.

Authors:  Chris Dockendorff; Patrick W Faloon; Jun Pu; Miao Yu; Stephen Johnston; Melissa Bennion; Marsha Penman; Thomas J F Nieland; Sivaraman Dandapani; José R Perez; Benito Munoz; Michelle A Palmer; Stuart L Schreiber; Monty Krieger
Journal:  Bioorg Med Chem Lett       Date:  2015-04-01       Impact factor: 2.823

6.  Influence of physicochemical properties of silver nanoparticles on mast cell activation and degranulation.

Authors:  Abdullah A Aldossari; Jonathan H Shannahan; Ramakrishna Podila; Jared M Brown
Journal:  Toxicol In Vitro       Date:  2015-02       Impact factor: 3.500

7.  Intratumoral delivery of CpG-conjugated anti-MUC1 antibody enhances NK cell anti-tumor activity.

Authors:  Jorge Schettini; Amritha Kidiyoor; Dahlia M Besmer; Teresa L Tinder; Lopamudra Das Roy; Joseph Lustgarten; Sandra J Gendler; Pinku Mukherjee
Journal:  Cancer Immunol Immunother       Date:  2012-04-28       Impact factor: 6.968

Review 8.  Scavenger receptor B type 1: expression, molecular regulation, and cholesterol transport function.

Authors:  Wen-Jun Shen; Shailendra Asthana; Fredric B Kraemer; Salman Azhar
Journal:  J Lipid Res       Date:  2018-05-02       Impact factor: 5.922

9.  Intracellular processing of immunostimulatory CpG-siRNA: Toll-like receptor 9 facilitates siRNA dicing and endosomal escape.

Authors:  Sergey Nechaev; Chan Gao; Dayson Moreira; Piotr Swiderski; Agnieszka Jozwiak; Claudia M Kowolik; Jiehua Zhou; Brian Armstrong; Andrew Raubitschek; John J Rossi; Marcin Kortylewski
Journal:  J Control Release       Date:  2013-06-15       Impact factor: 9.776

Review 10.  B-lymphocyte calcium influx.

Authors:  Leslie B King; Bruce D Freedman
Journal:  Immunol Rev       Date:  2009-09       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.